NEW YORK, NY / ACCESS Newswire / August 15, 2025 / If you suffered a loss on your Biohaven Ltd. (NYSE:BHVN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/biohaven-ltd-lawsuit-submission-form?prid=161702&wire=1&utm_campaign=20 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call […]

NEW YORK, NY / ACCESS Newswire / August 15, 2025 / If you suffered a loss on your Sable Offshore Corp. (NYSE:SOC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/sable-offshore-corp-lawsuit-submission-form?prid=161701&wire=1&utm_campaign=4 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

NEW YORK CITY, NY / ACCESS Newswire / August 15, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ:LNTH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Lantheus and certain of its officers and/or

Franchisor Celebrates Landmark Year, Recognizing Over 400 Sales Professionals FASTSIGNSInternational, Inc., the world's leading custom sign and visual solutions franchisor with more than 780 FASTSIGNS® centers worldwide, hosted its 15th annual Outside Sales Summit August 7-9 in St. Louis, Missouri. The event hosted over 640 participants, including franchisees, sales professionals, corporate staff and exhibitors. https://mma.prnewswire.com/media/2751115/FASTSIGNS_2025_Outside_Sales_Summit.jpg

NEW YORK, NY / ACCESS Newswire / August 15, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Inspire Medical Systems, Inc. ("Inspire" or the "Company") (NYSE:INSP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Inspire and certain of its officers and/or

NEW YORK CITY, NY / ACCESS Newswire / August 15, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Unicycive Therapeutics, Inc. ("Unicycive" or the "Company") (NASDAQ:UNCY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Unicycive and certain of its officers and/or

NEW YORK CITY, NY / ACCESS Newswire / August 15, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Harrow, Inc. ("Harrow" or the "Company") (NASDAQ:HROW). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Harrow and certain of its officers and/or directors

NEW YORK CITY, NY / ACCESS Newswire / August 15, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Jasper Therapeutics, Inc. ("Jasper" or the "Company") (NASDAQ:JSPR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Jasper and certain of its officers and/or

NEW YORK CITY, NY / ACCESS Newswire / August 15, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Confluent, Inc. ("Confluent" or the "Company") (NASDAQ:CFLT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Confluent and certain of its officers and/or directors

NEW YORK CITY, NY / ACCESS Newswire / August 15, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Insperity, Inc. ("Insperity" or the "Company") (NYSE:NSP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Insperity and certain of its officers and/or directors